Roche’s XCELLigence System Designed To Reduce Animal Testing In Pharmaceutical Development

BOTOX® is an important medicine that over the last 15 years of clinical use has helped millions of patients with serious medical conditions worldwide. Pharmaceutical manufacturers using Clostridium botulinum toxin (BOTOX®) in drugs are required by the Food and Drug Administration (FDA) in the United States and by other worldwide health regulatory agencies to protect patients and consumers by assuring product safety and efficacy through animal testing and other methods.

More: continued here

Filed under: Biology on August 11th, 2008